Clinical Trial Update: Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating TQB2868 injection plus Anlotinib capsules with placebo and chemotherapy as first-line treatment for metastatic pancreatic ductal adenoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Anlotinib hydrochloride capsules (anlotinib hydrochloride)
• TQB2868 injection (TQB2868)

Snippet

Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | Conditions: Metastatic Pancreatic Ductal Adenocarcinoma | Phase 3 | Status: RECRUITING